Multiple noncoding exons 1 of nuclear receptors NR4A family (nerve growth factor-induced clone B, Nur-related factor 1 and neuron-derived orphan receptor 1) and NR5A1 (steroidogenic factor 1) in human cardiovascular and adrenal tissues

Journal of Hypertension

Volumn 29, Issue 6, 2011, Pages 1185-1195

  Demura, Masashi ^a   Wang, Fen ^a   Yoneda, Takashi ^a   Karashima, Shigehiro ^a   Mori, Shunsuke ^a   Oe, Masashi ^a   Kometani, Mitsuhiro ^a   Sawamura, Toshitaka ^a   Cheng, Yuan ^a   Maeda, Yuji ^b   Namiki, Mikio ^b   Ino, Hidekazu ^a   Fujino, Noboru ^a   Uchiyama, Katsuharu ^a   Tsubokawa, Toshinari ^a   Yamagishi, Masakazu ^a   Nakamura, Yasuhiro ^c   Ono, Katsuhiko ^c   Sasano, Hironobu ^c   Demura, Yoshiki ^d   Takeda, Yoshiyu ^a   more..

^a KANAZAWA UNIVERSITY   (Japan)

^b Department of Urology ^*  (Japan)

^c TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d ISHIKAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

adrenal cortex; aldosterone producing adenoma; artery; cardiac muscle; CYP11B2; noncoding exon; nuclear receptor

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; CELL NUCLEUS RECEPTOR; CYCLIC AMP; NUCLEAR RECEPTOR NR4A3; NUCLEAR RECEPTOR NR5A1; NUCLEAR RECEPTOR NUR77; NUCLEAR RECEPTOR RELATED FACTOR 1; POTASSIUM CHLORIDE; STEROIDOGENIC FACTOR 1; UNCLASSIFIED DRUG;

ADENOMA; ADRENAL CORTEX CELL; ADRENAL GLAND; ALTERNATIVE NONCODING EXON 1; ALTERNATIVE RNA SPLICING; ARTERY; ARTICLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; EXON; GENE EXPRESSION; HEART MUSCLE; HUMAN; HUMAN TISSUE; HYPERTROPHIC CARDIOMYOPATHY; MULTIPLEX POLYMERASE CHAIN REACTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 79955595412     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32834626bb     Document Type: Article

References (32)

1. Takeda Y, Miyamori I, Yoneda T, Iki K, Hatakeyama H, Blair IA, et al. Production of aldosterone in isolated rat blood vessels. Hypertension 1995; 25:170-173.
2. Takeda Y, Yoneda T, Demura M, Miyamori I, Mabuchi H. Sodium-induced cardiac aldosterone synthesis causes cardiac hypertrophy. Endocrinology 2000; 141:1901-1904. (Pubitemid 32274421)
3. Gomez-Sanchez CE, Zhou MY, Cozza EN, Morita H, Foecking MF, Gomez- Sanchez EP. Aldosterone biosynthesis in the rat brain. Endocrinology 1997; 138:3369-3373. (Pubitemid 27345690)
4. Hatakeyama H, Miyamori I, Fujita T, Takeda Y, Takeda R, Yamamoto H. Vascular aldosterone. Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells. J Biol Chem 1994; 269:24316-24320.
5. Keidar S, Kaplan M, Pavlotzky E, Coleman R, Hayek T, Hamoud S, et al. Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin- converting enzyme and the receptors for angiotensin II and aldosterone. Circulation 2004; 109:2213-2220. (Pubitemid 38625399)
6. Gamliel-Lazarovich A, Gantman A, Coleman R, Jeng AY, Kaplan M, Keidar S. FAD286, an aldosterone synthase inhibitor, reduced atherosclerosis and inflammation in apolipoprotein E-deficient mice. J Hypertens 2010; 28:1900-1907.
7. Savoia C, Touyz RM, Amiri F, Schiffrin EL. Selective mineralocorticoid receptor blocker eplerenone reduces resistance artery stiffness in hypertensive patients. Hypertension 2008; 51:432-439. (Pubitemid 351156429)
8. Bassett MH, Suzuki T, Sasano H, White PC, Rainey WE. The orphan nuclear receptors NURR1 and NGFIB regulate adrenal aldosterone production. Mol Endocrinol 2004; 18:279-290. (Pubitemid 38183928)
9. Bassett MH, White PC, Rainey WE. A role for the NGFI-B family in adrenal zonation and adrenocortical disease. Endocr Res 2004; 30:567-574. (Pubitemid 40070132)
10. Lu L, Suzuki T, Yoshikawa Y,Murakami O,Miki Y, Moriya T, et al. Nur-related factor 1 and nerve growth factor-induced clone B in human adrenal cortex and its disorders. J Clin Endocrinol Metab 2004; 89:4113-4118. (Pubitemid 39071520)
11. Shibata H, Kobayashi S, Kurihara I, Suda N, Yokota K, Murai A, et al.COUPTF and transcriptional co-regulators in adrenal steroidogenesis. Endocr Res 2004; 30:795-801. (Pubitemid 40070170)
12. Bassett MH, Zhang Y, Clyne C, White PC, Rainey WE. Differential regulation of aldosterone synthase and 11beta-hydroxylase transcription by steroidogenic factor-1. J Mol Endocrinol 2002; 28:125-135. (Pubitemid 34428762)
13. Ye P, Nakamura Y, Lalli E, Rainey WE. Differential effects of high and low steroidogenic factor-1 expression on CYP11B2 expression and aldosterone production in adrenocortical cells. Endocrinology 2009; 150:1303-1309.
14. Li LA, Chang YC, Wang CJ, Tsai FY, Jong SB, Chung BC. Steroidogenic factor 1 differentially regulates basal and inducible steroidogenic gene expression and steroid synthesis in human adrenocortical H295R cells. J Steroid Biochem Mol Biol 2004; 91:11-20.
15. Carninci P, Sandelin A, Lenhard B, Katayama S, Shimokawa K, Ponjavic J, et al. Genome-wide analysis of mammalian promoter architecture and evolution. Nat Genet 2006; 38:626-635. (Pubitemid 43927303)
16. Bulun SE, Lin Z, Imir G, Amin S, Demura M, Yilmaz B, et al. Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacol Rev 2005; 57:359-383. (Pubitemid 41196955)
17. Demura M, Reierstad S, Innes JE, Bulun SE. Novel promoter I.8 and promoter usage in the CYP19 (aromatase) gene. Reprod Sci 2008; 15:1044-1053.
18. Demura M, Martin RM, Shozu M, Sebastian S, Takayama K, Hsu WT, et al. Regional rearrangements in chromosome 15q21 cause formation of cryptic promoters for the CYP19 (aromatase) gene. Hum Mol Genet 2007; 16:2529-2541. (Pubitemid 47617720)
19. Demura M, Bulun SE. CpG dinucleotide methylation of the CYP19 I.3/II promoter modulates cAMP-stimulated aromatase activity. Mol Cell Endocrinol 2008; 283:127-132.
20. Ye P, Nakamura Y, Lalli E, Rainey WE. Differential effects of high and low steroidogenic factor-1 expression on CYP11B2 expression and aldosterone production in adrenocortical cells. Endocrinology 2009; 150:1303-1309.
21. Arkenbout EK, de Waard V, van Bragt M, van Achterberg TA, Grimbergen JM, Pichon B, et al. Protective function of transcription factor TR3 orphan receptor in atherogenesis: decreased lesion formation in carotid artery ligation model in TR3 transgenic mice. Circulation 2002; 106:1530-1535.
22. Pires NM, Pols TW, de Vries MR, van Tiel CM, Bonta PI, Vos M, et al. Activation of nuclear receptor Nur77 by 6-mercaptopurine protects against neointima formation. Circulation 2007; 115:493-500. (Pubitemid 46184201)
23. Young WF Jr. Clinical practice. The incidentally discovered adrenal mass. N Engl J Med 2007; 356:601-610. (Pubitemid 46220820)
24. Bonta PI, van Tiel CM, Vos M, Pols TW, van Thienen JV, Ferreira V, et al. Nuclear receptors Nur77, Nurr1, and NOR-1 expressed in atherosclerotic lesion macrophages reduce lipid loading and inflammatory responses. Arterioscler Thromb Vasc Biol 2006; 26:2288-2294. (Pubitemid 44465724)
25. Zhao Y, Bruemmer D. NR4A orphan nuclear receptors: transcriptional regulators of gene expression in metabolism and vascular biology. Arterioscler Thromb Vasc Biol 2010; 30:1535-1541.
26. Nomiyama T, Zhao Y, Gizard F, Findeisen HM, Heywood EB, Jones KL, et al. Deficiency of the NR4A neuron-derived orphan receptor-1 attenuates neointima formation after vascular injury. Circulation 2009; 119:577-586.
27. Alexander JH, Hafley G, Harrington RA, Peterson ED, Ferguson TB Jr, Lorenz TJ, et al. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV - a randomized controlled trial. JAMA 2005; 294:2446-2454. (Pubitemid 41627922)
28. Han J, Kim D, Morris KV. Promoter-associated RNA is required for RNAdirected transcriptional gene silencing in human cells. Proc Natl Acad Sci USA 2007; 104:12422-12427. (Pubitemid 47206153)
29. Napoli S, Pastori C, Magistri M, Carbone GM, Catapano CV. Promoterspecific transcriptional interference and c-myc gene silencing by siRNAs in human cells. EMBO J 2009; 28:1708-1719.
30. Pearen MA, Muscat GE. Minireview: nuclear hormone receptor 4A signaling - implications for metabolic disease. Mol Endocrinol 2010; 24:1891-1903.
31. Myers SA, Eriksson N, Burow R, Wang SC, Muscat GE. Beta-adrenergic signaling regulates NR4A nuclear receptor and metabolic gene expression in multiple tissues. Mol Cell Endocrinol 2009; 309:101-108.
32. Wang H, Li R, Hu Y. The alternative noncoding exons 1 of aromatase (Cyp19) gene modulate gene expression in a posttranscriptional manner. Endocrinology 2009; 150:3301-3307.